Management of hyponatraemia and hypernatraemia during the Covid-19 pandemic: a consensus statement of the Spanish Society for Endocrinology (Acqua Neuroendocrinology Group)
| Autor: | Jorge Ruiz Sanchez, Alberto Fernandez Martinez, David Barajas Galindo |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Consensus Coronavirus disease 2019 (COVID-19) Endocrinology Diabetes and Metabolism Length of hospitalization 030209 endocrinology & metabolism Physical examination Neuroendocrinology Article 03 medical and health sciences 0302 clinical medicine Endocrinology Internal medicine Pandemic medicine SARS-COV2 Humans Societies Medical Hypernatremia medicine.diagnostic_test business.industry Morbidity risk Hyponatraemia COVID-19 Hypernatraemia Spain Dysnatremia Practice Guidelines as Topic business Water balance disorders Hyponatremia |
| Zdroj: | Reviews in Endocrine and Metabolic Disorders Reviews in Endocrine & Metabolic Disorders |
| ISSN: | 1573-2606 1389-9155 |
| DOI: | 10.1007/s11154-021-09627-3 |
| Popis: | SARS-COV2 infection has swiftly become a pandemic disease of historic relevance and widely variable outcomes. This variable prognosis is related both to uneven damage, among others, to lungs, heart and kidneys, and to a multisystemic inflammatory reaction. All these factors are known to disrupt water balance and potentially induce hyponatraemia or hypernatraemia. Water balance disorders are known mortality and morbidity risk factors in several clinical scenarios and their proper management, though often complex and hazardous, can reduce mortality and length of hospitalization. Clinical uncertainty over COVID-19 outcome, the variety of organs involved in both the infection and water balance and difficulties in clinical examination due to risk of contagion might obstruct proper management of dysnatremic disorders. Thus, the Acqua Neuroendocrinology Group of the Spanish Society for Endocrinology (SEEN) has endeavoured to provide evidence and expert based recommendations on the management of hyponatraemia and hypernatraemia in COVID-19 patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink